Related Experiment Video

Updated: May 14, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

[Experimental study on delta-tocotrienol inhibits the Wnt pathway in the colon cancer cell SW620]

M A Yue1, Ning He, Jing Zhang

  • 1Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China. xiaoma3477@sina.cn

Wei Sheng Yan Jiu = Journal of Hygiene Research
|February 22, 2013
PubMed
Abstract

Insights

Delta-tocotrienol significantly inhibits human colon cancer cell proliferation by downregulating key Wnt signaling pathway factors, including Wnt-1 and beta-catenin.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Context:

  • Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide.
  • The Wnt signaling pathway is frequently dysregulated in CRC, promoting tumor growth and proliferation.
  • Delta-tocotrienol, a form of vitamin E, has demonstrated potential antitumor properties.

Purpose:

  • To investigate the antiproliferative effects of delta-tocotrienol on human colon cancer cells (SW620).
  • To elucidate the relationship between delta-tocotrienol treatment and the Wnt signaling pathway.
  • To examine the impact of delta-tocotrienol on the expression of Wnt-1, beta-catenin, c-jun, and cyclin D1.

Summary:

  • Delta-tocotrienol exhibited a significant dose-dependent inhibition of SW620 cell proliferation, with an IC50 of 15.18 micromol/L and a 70.43% inhibition rate at tested concentrations.
  • Western blotting and immunocytochemistry revealed that delta-tocotrienol treatment led to a significant downregulation of Wnt-1, beta-catenin, c-jun, and cyclin D1 expression (P < 0.05).

Impact:

  • These findings suggest that delta-tocotrienol's anti-proliferative action on colon cancer cells is mediated, at least in part, by the suppression of the Wnt signaling pathway.
  • Delta-tocotrienol represents a potential therapeutic agent for colorectal cancer, warranting further investigation.
  • Understanding the molecular mechanisms of delta-tocotrienol could lead to novel therapeutic strategies for CRC.

More Related Videos

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine06:24

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Published on: October 13, 2023

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...